<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Spontaneous <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of bone marrow erythroid precursors accounts for the <z:hpo ids='HP_0001903'>anemia</z:hpo> that characterizes most low-grade <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We have shown that <z:hpo ids='HP_0011420'>death</z:hpo> of these precursors involved the Fas-dependent activation of caspase-8 </plain></SENT>
<SENT sid="2" pm="."><plain>To explore the pathway leading from caspase-8 activation to <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, we transduced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> bone marrow CD34(+) cells with a lentivirus encoding <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) or endoplasmic reticulum (ER)-targeted Bcl-2 protein before inducing their erythroid differentiation </plain></SENT>
<SENT sid="3" pm="."><plain>Both WT-Bcl-2 and ER-targeted Bcl-2 prevented spontaneous and Fas-dependent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> erythroid precursors </plain></SENT>
<SENT sid="4" pm="."><plain>ER-targeted Bcl-2 inhibited <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane depolarization and <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> release in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> erythroid precursors undergoing <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, indicating a role for the ER in the <z:hpo ids='HP_0011420'>death</z:hpo> pathway, upstream of the mitochondria </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> erythroid precursors demonstrated elevated ER Ca(2+) stores and these stores remained unaffected by ER-targeted Bcl-2 </plain></SENT>
<SENT sid="6" pm="."><plain>The ER-associated protein Bcl-2-associated protein (<z:chebi fb="1" ids="29022">BAP</z:chebi>) 31 was cleaved by caspase-8 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> erythroid precursors undergoing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>The protective effect of ER-targeted Bcl-2 toward spontaneous and Fas-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> correlated with inhibition of BAP31 cleavage </plain></SENT>
<SENT sid="8" pm="."><plain>A protective effect of erythropoietin against Fas-induced BAP31 cleavage and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was observed </plain></SENT>
<SENT sid="9" pm="."><plain>We propose that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> erythroid precursors involves the ER, downstream of Fas and upstream of the mitochondria, through the cleavage of the ER-associated BAP31 protein </plain></SENT>
</text></document>